Frontline Medical Sciences and Pharmaceutical Journal (FMSPJ) follows a rigorous Double-Blind Peer Review Systemthrough the Open Journal Systems (OJS) platform to ensure the quality, originality, integrity, and scientific value of all published manuscripts. In the double-blind review process, the identities of both authors and reviewers remain confidential throughout the evaluation process.
After manuscript submission, the Editorial Office conducts an initial screening to verify compliance with the journal's scope, formatting requirements, ethical standards, and plagiarism policies. Manuscripts that do not meet the basic requirements may be returned to authors for correction or rejected before peer review.
Submissions that pass the initial screening are assigned to an Editor who evaluates the manuscript's relevance, originality, scientific merit, and overall suitability for publication. Suitable manuscripts are then sent to qualified independent reviewers with expertise in the relevant subject area.
Reviewers evaluate the manuscript based on several criteria, including:
- Originality and significance of the research
- Scientific and technical quality
- Methodological rigor
- Accuracy of data analysis and interpretation
- Relevance to the journal's scope
- Quality of writing and presentation
- Ethical compliance and research integrity
Based on reviewers' recommendations, the Editor may make one of the following decisions:
- Accept Submission
- Revisions Required
- Resubmit for Review
- Decline Submission
When revisions are requested, authors are provided with reviewer comments and are expected to submit a revised manuscript along with a detailed response explaining how the comments have been addressed. Revised manuscripts may be returned to the original reviewers for further evaluation when necessary.
The final publication decision is made by the Editor-in-Chief or the designated Handling Editor after considering all reviewer reports and editorial recommendations.
The journal is committed to maintaining confidentiality throughout the review process. Reviewers are expected to treat all submitted manuscripts as confidential documents and to disclose any potential conflicts of interest before accepting a review assignment.
To uphold academic integrity, all submitted manuscripts are screened for plagiarism and publication ethics compliance before acceptance. Manuscripts containing substantial plagiarism, data fabrication, falsification, or unethical research practices will be rejected immediately.
The journal strives to complete the review process efficiently while maintaining high scholarly standards. The average review and editorial decision period may vary depending on reviewer availability, manuscript complexity, and the extent of revisions required.
Through its OJS-based double-blind peer review system, Frontline Medical Sciences and Pharmaceutical Journal ensures that all published articles meet internationally recognized standards of academic quality, scientific rigor, and research ethics.